News Release
Maruho Announces Executive Personnel Changes and New Executive Structure
Osaka (Japan), December 21, 2020 - Maruho Co., Ltd ("Maruho", Head Office: Osaka, Japan) announces that as of December 18, 2020, Representative Directors, Board of Directors and Corporate Officers have been changed, in addition to a new executive structure as stated below.
<Executive Personnel Changes>
Representative Directors
| Name | New Title | Previous Title |
| Koichi Takagi | Representative Director, Chairman of the Board |
Representative Director, President & CEO |
| Atsushi Sugita | Representative Director, President & CEO |
Director of the Board, Executive Vice President |
Profile of Representative Director, President & CEO
| March, 2012 | Entered Company |
| October, 2013 | Associate General Manager, Global Business Development Dept. |
| October, 2014 | Corporate Officer, North American Region |
| December, 2014 | Director of the Board, Corporate Officer, North American Region |
| January, 2016 |
Director of the Board, Corporate Officer, Corporate Planning, Global Business Management |
| December, 2016 | Director of the Board, Senior Corporate Officer, Global Strategy & Business Development, Finance & Accounting, Human Resources |
| October, 2018 | Director of the Board, Executive Corporate Officer, Business Operations & Administration |
| January, 2020 | Director of the Board, Executive Vice President |
| December, 2020 | Representative Director, President & CEO(Current) |
Atsushi Sugita
| Birthdate: | June 24, 1974 (46 years old) |
| Birthplace: | Osaka Prefecture |
| Academic Background: | Graduated from Faculty of Economics, Kyoto University Master's degree from Kellogg School of Management, Northwestern University |
<New Executive Structure>
１．Board of Directors and Auditors
| Representative Director, Chairman of the Board | Koichi Takagi |
| Representative Director, President & CEO | Atsushi Sugita |
| Director of the Board | Yasuyuki Ishimaru |
| Director of the Board | Yasuhiko Kito |
| Director of the Board | Masahiro Takeda |
| Director of the Board | Takashi Kitagawa (New) |
| Director of the Board | Junichi Hamada (New) |
| Director of the Board (Outside) | Akihiro Watanabe |
| Director of the Board (Outside) | Yoshihiko Akagi |
| Director of the Board (Outside) | Toshio Asano |
| Corporate Audit & Supervision | Hiroaki Miura |
*As of December 18, 2020, Director of the Board Tetsuto Takaki was appointed as an advisor.
２．Corporate Officers
| President & CEO | Atsushi Sugita |
| Executive Corporate Officer | Yasuyuki Ishimaru |
| Senior Corporate Officers | |
| Global Business Development & Drug Discovery Research | Junichi Hamada |
| Research & Development, Reliability Assurance & Medical Affairs | Yasuhiko Kito |
| Japan Business Operations | Takashi Kitagawa |
| Corporate Planning, Business Operations, CMC Research & Production | Masahiro Takeda |
| Corporate Officers | |
| General Manager, Drug Discovery Research Department | Kazumasa Hirata |
| Research & Development | Yutaka Ishihama |
| Reliability Assurance & Medical Affairs | Yoshimi Kakiuchi |
| Sales | Yoshihiko Sato |
| Business Operations | Koichi Nishioka |
| Production | Katsunori Hiratsuka |